Annual Report

Overview

The report covers the 2023/2024 year and highlights positive interim results for the Phase 3 DIAGNODE-3 trial, which proceeded without modifications. It describes progress toward in-house recombinant GAD65 manufacturing in Umeå and identifies SDGs 3, 9 and 12 as priority goals. The Group reported MSEK 4.4 in revenues and 28 employees at August 31, 2024.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2023-2024
Period: 1 September 2023 – 31 August 2024
Language: English
Pages
File size

Reporting standards, commitments and assurance details are available with a free account.

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services